Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Optimal testing strategy for patients with suspected CAD remains unclear Erik Swain
• FDA approves alirocumab for lowering of LDL in certain patients
• FDA approves new treatment for HF
• FDA strengthens warning of link between NSAIDs and MI, stroke
• FDA’s decree to ban artificial trans fats expected to reduce CHD
• AQUAMARINE: Statin therapy reduces high-intensity plaques in patients with CAD
• Bridging anticoagulation unnecessary in patients with AF who stop warfarin before procedure
• CARDIO-FIT: High cardiorespiratory fitness protects against AF recurrence in patients with obesity
• CHD linked to osteoporosis in older adults
• Extended anticoagulation beneficial after pulmonary embolism
• Female gender predicted late survival in TAVR
• Guideline update recommends stent-retrieval devices to treat certain patients with stroke
• Health insurance expansion may improve hypertension treatment
• ICDs underutilized in elderly patients after MI
• Incidence of infective endocarditis increased in past decade
• LEVANT 2 published: DCB superior to standard angioplasty for treatment of PAD
• New BP guidelines reclassify 1 in 6 older adults as achieving targets
• Prolonged smoking cessation reduces mortality, HF risk in mild/moderate smokers
• Robotic-assisted cardiac surgery reduces length of stay, complications, mortality
• Seismic scale of earthquakes, aftershocks tied to frequency of acute MI
• Societies release recommendations for implantation of percutaneous LAA occlusion devices
• Supervised exercise may help improve walking in patients with claudication
• Trauma, PTSD may be risk factors for cardiovascular disease among women
• VA/Department of Defense guideline supports elimination of lipid targets
• ABIM to eliminate underlying certification requirement for nine subspecialties
• ACC launches Statin Intolerance App
• AHA survey reveals misconceptions about HF in US
• IOM report calls for national cardiac arrest registry, more CPR training
• Keith C. Ferdinand, MD, a front-runner in patient care
• Baroreflex activation therapy may benefit HF patients without CRT
• Educating patients with HF requires multidisciplinary approach
• Genetic variant reduces coronary events, increases diabetes risk in familial hypercholesterolemia
• No new danger for CV events with Farxiga in older adults
• No additional threat of heart failure with Januvia in high-risk adults with type 2 diabetes
• Smartphones, power lines may affect some implantable cardiac devices
• Younger, older HF patients require different disease management
• Cardiology Today offers resource on managing STEMI with PCI
• Trial Scorecard: AQUAMARINE
• Trial Scorecard: CARDIO-FIT
• Trial Scorecard: CHANCE
• Trial Scorecard: COMES
• Trial Scorecard: EPIPAGE 2
• Trial Scorecard: EVOLVE
• Trial Scorecard: EXPERT CTO
• Trial Scorecard: RIBS IV